SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is experiencing an intense rally driven by a structural memory supercycle, where extreme demand for AI-optimized HBM and DRAM has created a persistent supply bottleneck expected to last through 2027. Community sentiment is overwhelmingly bullish, with investors aggressively debating the potential for a stock split and further valuation rerating as the company transitions from a cyclical memory maker to critical AI infrastructure.

Aventus Network

Aventus Network is capturing community attention as traders speculate on a potential breakout driven by its integration with Polkadot and recent strategic expansion into the UAE through the appointment of a new advisor. Investors are highlighting the project's low market capitalization and enterprise-grade partnerships as bullish indicators while actively monitoring trading volume for signs of sustained momentum.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Moderna is trending as investors focus on the company's progress with mRNA-based pipeline developments, including an investigational cancer therapy and a combination vaccine for flu and COVID-19. The stock is seeing heightened activity fueled by positive institutional sentiment and active discussions regarding potential breakthroughs in its oncology platform.

Destiny Tech100, Inc. operates as a non-diversified, closed-end management investment company. The company was founded on November 18, 2020 and is headquartered in Austin, TX.

Destiny Tech100 Inc

DESTINY TECH 100 INC

Destiny Tech 100 is drawing significant investor interest as a primary proxy for pre-IPO exposure to high-profile companies like SpaceX and Anthropic. Community discussion is focused on the fund's potential Net Asset Value upside, the anticipation surrounding upcoming IPO timelines, and debate over its valuation premium compared to broader market alternatives.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

The SPY is experiencing a contentious tug-of-war as investors balance persistent geopolitical tensions in the Middle East and rising energy prices against a resilient, AI-driven market rally. Community discourse is currently split between traders aggressively betting on new all-time highs fueled by persistent mega-cap momentum and skeptics who are increasingly wary of extreme market concentration and potential liquidity risks.

NovaChargeX Coin (NCX) is an Ethereum-based ERC-20 token connected to NovaChargeX LLC, a clean-energy company developing patented hybrid regenerative power systems designed to deliver continuous, grid-independent electricity. The token serves as the on-chain entry point to the NovaChargeX ecosystem, linking blockchain participants to a real-world infrastructure project focused on supplying 24/7 power to AI data centers, industrial facilities, and other operations that cannot tolerate downtime. NCX is positioned in the real-world asset (RWA) and clean-energy infrastructure category. The parent company has been recognized by the World Future Awards 2025 for Best Hybrid Regenerative Clean Energy System and has received coverage from Al Arabiya English, SolarQuarter, and Reuters. The token contract is deployed on Ethereum mainnet, ownership has been renounced, and a third-party security audit has been completed.

NovaChargeX Coin

NovaChargeX is capturing investor interest as market participants highlight its integration of clean energy infrastructure with blockchain and AI power demand. The community is actively discussing the project's real-world utility and emerging real-world asset narrative as a potential alternative to speculative meme tokens.

Rackspace Technology, Inc. engages in the provision of end-to-end multi-cloud technology services. The firm designs, builds and operates its customers’ cloud environments across technology platforms. It operates through the following segments: Multicloud Services and Apps & Cross Platform. The Multicloud Services segment includes public and private cloud managed services offerings, as well as professional services related to designing and building multicloud solutions and cloud-native applications. The Apps & Cross Platform segment includes managed applications, managed security and data services, as well as professional services related to designing and implementing application, security and data services. The company was founded on July 21, 2016 and is headquartered in San Antonio, TX.

Rackspace Technology Inc

Rackspace Technology is trending due to a combination of Q1 profitability and a new memorandum of understanding with AMD to develop enterprise AI infrastructure, triggering a significant rally and active short-squeeze speculation. Community discussions are split between bulls betting on a major AI-driven turnaround and bears warning of potential equity dilution to manage the company's substantial debt load.

Digi Power X, Inc. is a block chain technology company, which engages in crypto currency mining. It focuses on validation through mining, hosting solutions, and blockchain software solutions. It operates through the following segments: Cryptocurrency Mining, Sales of Energy and Electricity, and Colocation Services. The company was founded on February 18, 2017, and is headquartered in Miami, FL.

Digi Power X Inc. - Ordinary Shares (Sub voting)

Digi Power X is rallying on investor optimism surrounding a major colocation deal with Cerebras Systems, which investors see as a strategic proxy play for the upcoming Cerebras IPO. The community is actively debating the stock's valuation upside and potential re-rating as a key AI infrastructure provider, despite ongoing discussions about capital management and share offerings.

The KARRAT protocol is a decentralized gaming infrastructure layer, supported by $KARRAT and empowered by a truly decentralized community with a shared vision embracing gaming, entertainment and AI products catering for the new era.  To accelerate the evolution of gaming, entertainment, and AI-driven experiences with blockchain technology and a truly empowered community.  The KARRAT protocol pioneers a decentralized framework in gaming and entertainment, combining blockchain with community-driven collaboration. $KARRAT can animate ecosystems of games and products and the protocol makes tools available to support these industries and the adoption of KARRAT technology provides a unique, personalized gaming experience.

KARRAT

KARRAT is gaining traction as investors anticipate a major breakout, driven by its strategic positioning in the Web3 gaming sector and infrastructure integrations like StudioChain. The community is actively discussing potential explosive growth, with many traders accumulating tokens while debating the project's technical setup and long-term potential against a backdrop of broader altcoin market sentiment.

Zepp Health Corp. engages in the development of smart wearable health and consumer fitness devices. It empowers users to achieve their well-being goals by optimizing their health, fitness, and wellness journeys. Its brands include Amazfit, Zepp Clarity, and Zepp Aura. The company was founded by Huang Wang in 2013 and is headquartered in Gorinchem, Netherlands.

Zepp Health Corporation - ADR

Huami Corp

Huami Corp is experiencing significant momentum as investors digest its high-growth potential in the wearable AI market, with the community actively comparing its valuation and product efficacy against industry rivals like Garmin and Whoop. Bullish sentiment is being driven by institutional interest and excitement over recent product launches, while skeptical traders continue to debate whether this rapid price appreciation is a sustainable rerating or an overextended speculative move.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Estrella Immunopharma to Participate in the D. Boral Capital Global Conference

Estrella Immunopharma, Inc. (NASDAQ: ESLA; ESLAW) (Estrella or the Company), a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies to treat cancer and...

Short Interest in Estrella Immunopharma, Inc. (NASDAQ:ESLA) Declines By 57.6%

Estrella Immunopharma, Inc. (NASDAQ:ESLA - Get Free Report) was the recipient of a large decrease in short interest during the month of April. As of April 15th, there was short interest totaling 265,805 shares, a decrease of 57.6% from the March 31st total of 626,324 shares. Based on an average...

Estrella Immunopharma (NASDAQ:ESLA) Trading Up 26.5% - Here's Why

Estrella Immunopharma (NASDAQ:ESLA) Shares Up 26.5% - Here's What Happened...

Estrella Immunopharma, Inc. (NASDAQ: ESLA) Receives Initiating Coverage with a Valuation of $12.00/Share from Zacks Small-Cap Research

D. Boral Capital Reiterates Buy Rating for Estrella Immunopharma (NASDAQ:ESLA)

D. Boral Capital reissued a "buy" rating and issued a $8.00 price target on shares of Estrella Immunopharma in a research report on Monday...

Estrella Immunopharma Presents Promising Updated Data on EB103 in Oral Presentation at the 2026 Tandem Meetings of ASTCT & CIBMTR

Estrella Immunopharma, Inc. (Nasdaq: ESLA, ESLAW) (Estrella or the Company), a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies to treat cancer and...

Estrella Immunopharma Announces Late-Breaking Oral Presentation of Phase 1 STARLIGHT-1 Data for EB103 at the 2026 Tandem Meetings of ASTCT & CIBMTR

Estrella Immunopharma, Inc. (Nasdaq: ESLA) (Estrella or the Company), a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies to treat cancer and...

Estrella Immunopharma, Inc. Announces $8.0 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules

Estrella Immunopharma, Inc. (NASDAQ: ESLA) (the Company), a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies to treat cancers and autoimmune...

Short Interest in Estrella Immunopharma, Inc. (NASDAQ:ESLA) Grows By 28.5%

Estrella Immunopharma, Inc. (NASDAQ:ESLA - Get Free Report) saw a large increase in short interest in the month of December. As of December 15th, there was short interest totaling 709,318 shares, an...

Estrella Immunopharma (NASDAQ:ESLA) Trading 1.3% Higher - Here's Why

Estrella Immunopharma (NASDAQ:ESLA) Trading 1.3% Higher - What's Next...

Estrella Immunopharma, Inc. operates as a pre-clinical stage biopharmaceutical company, which engages in the development of T-cell therapies for patients with cancers and autoimmune diseases. The company was founded on March 30, 2022 and is headquartered in Emeryville, CA.

Estrella Immunopharma Inc

Up > 1%

Flat +/- 1%

Down > 1%

Where does the $SPY finish next week vs. Friday’s close?

ESLA
Estrella Biopharma Inc

Feed

News

Sentiment

Fundamentals

Info

Compact View

Poll

Latest ESLA News

ESLAEstrella Biopharma Inc